BC Week In Review | Sep 3, 2012
Clinical News

DESyne BD Novolimus Eluting Coronary Stent System regulatory update

Elixir received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System to treat coronary artery disease (CAD). Elixir plans to launch the novolimus-eluting cobalt chromium alloy stent with a biodegradable polylactide-based polymer...
Items per page:
1 - 1 of 1